Perimenopause Blood Tests: What They Can—and Cannot—Tell You

Perimenopause blood tests can provide useful information, but they cannot reliably confirm or rule out perimenopause in most people.

This is because perimenopause is a period of hormonal fluctuation rather than a single, stable hormonal state. Oestrogen and follicle-stimulating hormone levels can change considerably between menstrual cycles—and sometimes within the same cycle. A blood result may therefore look “normal” on one day even when a person is experiencing genuine and disruptive perimenopausal symptoms.

For otherwise healthy people aged 45 and over who have typical symptoms, perimenopause is usually identified from symptoms and changes in the menstrual cycle rather than confirmed through hormone testing. Blood tests become more relevant when symptoms begin at a younger age, the diagnosis is unclear, hormonal contraception is masking menstrual changes, or another condition could be causing similar symptoms.

The most important question is not simply, “Can I get a blood test for perimenopause?” It is:

What clinical question is the test intended to answer?

A well-selected blood test may help investigate thyroid dysfunction, anaemia, iron deficiency, pregnancy, premature ovarian insufficiency or another possible explanation for symptoms. A broad hormone panel ordered without a clear purpose may provide numbers without providing clarity.

What perimenopause blood tests can tell you

Depending on your age, symptoms, menstrual history and medication use, blood tests may help:

• Investigate menopause-related symptoms occurring before the age of 45
• Support the assessment of suspected premature ovarian insufficiency before the age of 40
• Exclude other conditions that can resemble perimenopause
• Identify iron deficiency or anaemia caused by heavy or prolonged periods
• Assess thyroid function when symptoms overlap
• Investigate irregular or absent periods that may have another cause
• Review selected health risks before or during treatment
• Clarify unexpected bleeding, fertility concerns or signs of androgen excess
• Monitor a known condition when there is a specific clinical reason

What blood tests generally cannot do is provide a simple yes-or-no answer that proves someone is in perimenopause.

They also cannot reliably predict when the final menstrual period will happen, how long symptoms will last, whether hormone replacement therapy will work or when contraception can safely be stopped.

What perimenopause blood tests cannot reliably tell you

A single hormone result cannot reliably determine:

• Whether you are definitely in perimenopause
• Whether your symptoms are “real”
• How severe your symptoms should feel
• When you will reach menopause
• How long the transition will last
• Whether you will benefit from treatment
• Which hormone replacement therapy dose you need
• Whether you can stop using contraception
• Whether every symptom is caused by hormonal change
• Whether a normal result means perimenopause has been excluded

These limitations are important because private hormone panels are often presented as though they can produce certainty from a single sample. In reality, interpreting perimenopause requires more than measuring reproductive hormones on one particular day.

Why perimenopause is difficult to diagnose with a blood test

Perimenopause is the transitional stage leading up to menopause. During this time, ovarian function becomes less predictable. Ovulation may occur normally in one cycle, happen later than expected in another and not happen at all in the next.

As a result, levels of oestrogen, progesterone and follicle-stimulating hormone can rise and fall unpredictably.

This means two people with similar symptoms may receive very different hormone results. It also means the same person could be tested twice and receive noticeably different results each time.

A result taken on a day when hormone levels appear typical does not prove that the wider transition is not happening.

The NICE guideline on identifying and managing menopause advises diagnosing perimenopause without laboratory tests in otherwise healthy people aged 45 and over who have vasomotor symptoms, such as hot flushes or night sweats, alongside changes in their menstrual cycle.

The diagnosis is clinical because the pattern of symptoms and menstrual changes is often more informative than a single hormone measurement.

Perimenopause testing by age

Age has a significant influence on whether hormone testing is likely to provide useful information.

These are general principles rather than rigid rules. A clinician may recommend testing outside these situations when the history creates a specific reason.

Do you need a blood test for perimenopause after 45?

Most people aged 45 or over with typical perimenopausal symptoms do not need a hormone blood test to confirm the diagnosis.

Typical symptoms may include:

• Hot flushes
• Night sweats
• Changes in menstrual timing or flow
• Sleep disturbance
• Low mood
• Anxiety
• Reduced concentration
• Memory difficulties
• Vaginal dryness
• Pain during sex
• Reduced sexual desire
• Headaches or migraines
• Joint or muscle discomfort
• Palpitations
• Changes in bladder symptoms

Menstrual changes may involve shorter cycles, longer cycles, missed periods, heavier bleeding or lighter bleeding. Symptoms do not always begin at the same time, and some people experience significant symptoms before their periods become noticeably irregular.

The NICE quality standard for diagnosing perimenopause and menopause states that people aged 45 and over should generally be diagnosed from their symptoms rather than through confirmatory laboratory testing.

This does not mean blood tests are never useful after 45. They may still be appropriate when the objective is to investigate another possible cause of the symptoms rather than to “prove” perimenopause.

For example, persistent fatigue, palpitations, unusually heavy periods and feeling cold could justify checking for anaemia, iron deficiency or thyroid dysfunction.

When FSH testing may be useful

Follicle-stimulating hormone, usually abbreviated to FSH, is released by the pituitary gland. It stimulates the ovaries to develop follicles and produce oestrogen.

As ovarian activity declines, the body may produce more FSH in an attempt to stimulate the ovaries. A persistently elevated FSH level can therefore support a diagnosis of ovarian insufficiency or menopause in selected situations.

FSH testing may be considered when:

• Menopause-related symptoms begin between the ages of 40 and 45
• Menopause is suspected before the age of 40
• Menstrual cycles have stopped or become markedly irregular at an unexpectedly young age
• The diagnosis remains uncertain after reviewing symptoms and history
• A clinician is investigating possible ovarian insufficiency
• There is a medical reason to clarify ovarian function

However, FSH is not a perfect menopause test.

During perimenopause, FSH can move between high, normal and intermediate levels. One elevated result does not necessarily mean menopause has occurred, while one normal result does not exclude perimenopause.

What does a high FSH result mean?

A high FSH result may suggest that the ovaries are responding less consistently to stimulation. Its meaning depends on:

• Age
• Menstrual pattern
• Timing of the sample
• Symptoms
• Hormonal medication
• Pregnancy status
• Oestrogen levels
• Whether the result remains elevated when repeated
• The laboratory’s reference range

FSH should not be interpreted as a standalone diagnosis.

An elevated result in a 52-year-old with hot flushes and increasingly irregular periods has a different clinical meaning from the same result in a 29-year-old whose periods have unexpectedly stopped.

Can normal FSH rule out perimenopause?

No.

A normal FSH level cannot reliably rule out perimenopause because ovarian activity may fluctuate. The ovaries may function relatively normally during one cycle and less predictably during another.

A person may have typical symptoms and a normal result simply because the sample was taken during a temporary period of higher ovarian activity.

This is one reason routine FSH testing is generally not recommended for otherwise healthy people over 45 with typical symptoms.

Premature ovarian insufficiency and early menopause

Symptoms beginning before the usual age require a different level of attention.

Early menopause refers to menopause occurring before the age of 45. Premature ovarian insufficiency, sometimes called POI, refers to loss or marked reduction of ovarian function before the age of 40.

Premature ovarian insufficiency is not always identical to natural menopause. Ovarian activity can occasionally occur unpredictably, and some people may continue to ovulate intermittently.

Possible symptoms include:

• Periods becoming irregular or stopping
• Hot flushes
• Night sweats
• Vaginal dryness
• Difficulty conceiving
• Sleep disruption
• Mood changes
• Reduced sexual desire
• Problems with concentration

Because oestrogen has an important role in bone and cardiovascular health, suspected premature ovarian insufficiency requires proper assessment rather than reliance on an unverified home test.

The NHS guidance on early and premature menopause explains that hormone blood tests may be used when menopause is suspected before the age of 45.

When premature ovarian insufficiency is being considered, FSH may need to be measured on more than one occasion. The wider investigation may also consider pregnancy, thyroid function, prolactin, medication effects, medical treatments and possible underlying causes.

A single private test should not be used to diagnose or dismiss premature ovarian insufficiency without follow-up.

Common blood tests considered during a perimenopause assessment

There is no universal perimenopause panel that is appropriate for everyone. The most useful combination depends on the symptoms and the question being investigated.

The presence of a test on this list does not mean it should be routinely ordered. Testing is most useful when each marker has a clear purpose and a plan exists for interpreting and acting on the result.

FSH: useful in selected situations, unreliable as a universal answer

FSH is the test most commonly associated with menopause, but it is also one of the most frequently misunderstood.

An FSH result is a snapshot of communication between the brain and ovaries at the time the sample is collected. It is not a direct measurement of symptom severity and does not provide a countdown to menopause.

FSH levels may be affected by:

• The stage of the menstrual cycle
• Irregular ovulation
• Pregnancy
• Hormonal contraception
• Hormone replacement therapy
• Age
• Ovarian surgery or medical treatment
• Some pituitary conditions
• Laboratory methods

Repeated testing may be needed when assessing premature ovarian insufficiency, but repeatedly checking FSH in a person over 45 with typical symptoms rarely adds useful information.

Oestradiol: why one oestrogen result can be misleading

Oestradiol is one of the principal forms of oestrogen produced during the reproductive years.

It may seem logical to assume that perimenopause should produce a consistently low oestradiol result. In practice, levels may be low, normal or temporarily high.

Early in the transition, oestrogen production can become erratic rather than simply declining in a smooth line. Some cycles may involve significant oestrogen production, while others involve much less.

This fluctuation can contribute to symptoms such as:

• Breast tenderness
• Heavy bleeding
• Headaches
• Mood changes
• Bloating
• Hot flushes
• Sleep disruption

A single oestradiol result therefore cannot show the full hormonal pattern.

NICE advises against using oestradiol testing to identify perimenopause or menopause in otherwise healthy people over 45. The result may have a role in specialist or selected clinical situations, but it is not a routine confirmation test.

Progesterone: a test of ovulation, not a straightforward menopause test

Progesterone is produced after ovulation. Measuring it at the correct stage of the menstrual cycle can help indicate whether ovulation is likely to have occurred.

This can be useful during certain fertility investigations. It is less useful as a general test for perimenopause.

During perimenopause:

• Ovulation may occur in some cycles but not others
• Cycle length may change
• The expected testing day may no longer be accurate
• A low result may reflect timing rather than permanent ovarian decline
• A normal result may simply show that ovulation occurred during that cycle

Progesterone results are highly dependent on when the sample is taken. Testing on a fixed calendar day without considering the person’s actual cycle length can produce a result that is difficult to interpret.

LH: usually not needed to diagnose perimenopause

Luteinising hormone, or LH, is involved in triggering ovulation. Like FSH, it may change as ovarian function becomes less predictable.

LH is sometimes included in broad reproductive hormone panels, but it usually does not provide a clear answer about whether someone is in perimenopause.

It may be useful in selected investigations involving ovulation, fertility, absent periods or suspected endocrine conditions. It is not generally necessary for diagnosing typical perimenopause after the age of 45.

Anti-Müllerian hormone: not a menopause countdown

Anti-Müllerian hormone, known as AMH, is produced by cells surrounding developing ovarian follicles. It is commonly used in fertility care as one indicator of ovarian reserve.

AMH is sometimes marketed as a way to predict menopause. This interpretation goes beyond what an individual result can reliably provide.

A low AMH result may indicate a lower number of recruitable follicles, but it cannot precisely predict:

• The date of the final menstrual period
• Whether natural conception is possible
• How quickly ovarian function will change
• Whether symptoms are caused by perimenopause
• When contraception can be stopped

NICE advises against using AMH to identify perimenopause or menopause in people aged 45 and over.

AMH can provide useful information in fertility and specialist reproductive settings, but it should not be presented as a definitive menopause test.

Testosterone testing: when it may and may not help

Testosterone contributes to sexual function, bone health, muscle function and general wellbeing in people of all sexes. However, routine testosterone testing is not necessary for everyone experiencing perimenopausal symptoms.

Testing may be considered when there are signs of androgen excess, including:

• Increased facial or body hair
• Persistent or severe acne
• Rapid scalp hair thinning
• A deepening voice
• Significant menstrual irregularity
• Other signs of virilisation

Depending on the presentation, total testosterone may be assessed alongside sex hormone-binding globulin, often abbreviated to SHBG. These results require careful interpretation because testing methods, medicines and natural variation can affect the measurement.

A low testosterone result does not, by itself, explain fatigue, low mood or reduced sexual desire. These concerns can be influenced by sleep, stress, relationship factors, pain, medicines, depression, vaginal symptoms and several physical health conditions.

Testosterone levels are also not routinely used to diagnose perimenopause.

Thyroid function: an important alternative explanation

Thyroid disorders can produce symptoms that overlap substantially with perimenopause.

An underactive thyroid may cause:

• Fatigue
• Weight gain
• Feeling unusually cold
• Dry skin
• Hair changes
• Constipation
• Low mood
• Difficulty concentrating
• Heavy or irregular periods

An overactive thyroid may cause:

• Palpitations
• Anxiety
• Heat intolerance
• Increased sweating
• Sleep difficulties
• Weight loss
• Tremor
• Menstrual changes

Because these symptoms can resemble hormonal transition, thyroid function testing may be appropriate when the symptom pattern suggests it.

The initial test usually includes thyroid-stimulating hormone, or TSH. Free T4 may also be measured depending on the result, symptoms, medical history and laboratory process.

Testing thyroid function does not confirm perimenopause. It helps investigate another condition that may be causing or contributing to similar symptoms.

Full blood count and ferritin: important when periods become heavier

Perimenopause does not always begin with periods becoming lighter or less frequent. Some people experience heavier, longer or less predictable bleeding.

Repeated heavy bleeding can lead to iron deficiency and, eventually, iron-deficiency anaemia.

Possible symptoms include:

• Persistent tiredness
• Breathlessness
• Palpitations
• Headaches
• Reduced exercise tolerance
• Dizziness
• Pale skin
• Restless legs
• Hair shedding

A full blood count can help identify anaemia. Ferritin provides information about stored iron and may become low before haemoglobin falls below the laboratory range.

Blood tests can identify the consequences of heavy bleeding, but they do not explain why the bleeding is happening.

New, persistent or unusually heavy bleeding may require a clinical assessment. Depending on age, pattern, medication and medical history, further investigation may be needed rather than simply attributing the change to perimenopause.

A structured Perimenopause MOT may help identify relevant general health markers, but significant bleeding should still be discussed with an appropriate clinician.

Prolactin: relevant when periods stop for other reasons

Prolactin is a hormone produced by the pituitary gland. Its primary role is supporting milk production, but elevated levels can also interfere with ovulation and menstrual cycles.

High prolactin may be associated with:

• Irregular or absent periods
• Unexpected breast milk production
• Fertility difficulties
• Reduced sexual desire
• Headaches
• Changes in vision in uncommon but important cases

Prolactin can rise temporarily because of stress, exercise, sleep, breast stimulation and some medicines. A mildly elevated result may need to be repeated under more controlled conditions.

It is not a routine perimenopause test, but it may be useful when periods have stopped and the cause is uncertain.

Pregnancy testing remains relevant during perimenopause

Irregular periods do not mean pregnancy is impossible.

Ovulation becomes less predictable during perimenopause, but it can still occur. Pregnancy should therefore be considered when periods are late or absent, particularly if the person is sexually active and not using reliable contraception.

A menopause hormone test should not be used as a substitute for a pregnancy test.

Hormone replacement therapy is also not a contraceptive. People who do not wish to become pregnant may still need contraception until menopause has been established according to appropriate clinical guidance.

Blood glucose, cholesterol and cardiovascular health

Perimenopause blood testing is often discussed only in terms of reproductive hormones. However, a broader health review may sometimes be more useful.

Ageing, family history, body composition, blood pressure, smoking, sleep and physical activity all influence cardiovascular and metabolic health. The menopause transition may coincide with changes in cholesterol, insulin sensitivity and fat distribution, although individual risk varies.

Depending on personal risk factors, a clinician may consider:

• Blood pressure
• Lipid profile
• HbA1c or fasting glucose
• Weight and waist measurement
• Smoking status
• Family cardiovascular history

These tests do not diagnose perimenopause. They help build a more complete understanding of long-term health.

A person may have normal reproductive hormones but still benefit from identifying high cholesterol, raised glucose or another modifiable risk factor.

Vitamin D, vitamin B12 and folate

Fatigue, poor concentration, low mood and musculoskeletal discomfort are often attributed to perimenopause, but these symptoms are not specific.

Vitamin B12 or folate testing may be considered when there are risk factors such as:

• A vegan or highly restricted diet
• Malabsorption
• Previous stomach or intestinal surgery
• Persistent digestive symptoms
• Unexplained anaemia
• Numbness or tingling
• Long-term use of medicines that affect absorption

Vitamin D testing may be appropriate when there is a clear risk of deficiency, bone or muscle symptoms, malabsorption or another clinical reason.

These tests should not automatically be added to every menopause panel. They are most useful when the symptoms and medical history create a reasonable suspicion of deficiency.

Can blood tests tell you whether you need HRT?

Blood tests do not usually determine whether a person with typical perimenopausal symptoms should be offered hormone replacement therapy.

Treatment decisions are generally based on:

• Symptoms
• Age
• Menstrual history
• Personal preferences
• Medical history
• Current medication
• Pregnancy and contraception needs
• Potential benefits
• Individual risks
• Whether there are contraindications requiring specialist advice

A person does not need to demonstrate an abnormally low oestrogen result before their symptoms can be taken seriously.

Similarly, a normal FSH or oestradiol result does not necessarily mean treatment would be inappropriate.

The decision to use HRT should be made through an informed discussion about symptoms, expected benefits, possible risks and suitable treatment options.

Do hormone levels need to be monitored after starting HRT?

Routine hormone-level monitoring is not usually required for people using standard licensed HRT.

Treatment is generally reviewed according to:

• Symptom improvement
• Side effects
• Bleeding pattern
• Adherence
• Blood pressure where appropriate
• Changes in health or medication
• Whether the dose and formulation remain suitable

Oestradiol levels may be considered in selected specialist circumstances, such as persistent symptoms despite treatment, concerns about absorption or the management of premature ovarian insufficiency. They are not generally required for routine dose adjustment.

The goal of standard HRT is not to make every person reach one “ideal” blood hormone level. There is no universal numerical target that guarantees symptom control.

Symptoms, tolerability and clinical context are usually more important than chasing a specific laboratory result.

Why testing can be difficult while using hormonal contraception

Hormonal contraception can alter natural hormone production and bleeding patterns. This can make both symptoms and blood results more difficult to interpret.

Combined hormonal contraception, which contains oestrogen and a progestogen, suppresses the natural ovarian cycle. FSH and oestradiol results taken while using it generally do not provide a reliable picture of menopausal status.

Some progestogen-only methods can also change or stop bleeding, meaning the absence of periods cannot automatically be interpreted as menopause.

This applies to methods such as:

• Combined oral contraceptive pills
• Contraceptive patches
• Vaginal rings
• Progestogen-only pills
• Hormonal intrauterine systems
• Contraceptive injections
• Implants

Do not stop hormonal contraception solely to obtain a menopause blood test without discussing the implications with a qualified healthcare professional. Stopping treatment can lead to unintended pregnancy, heavy bleeding or the return of symptoms.

The choice of test—and whether testing is useful at all—depends on age, the type of contraception and the reason the information is needed.

What if you have had a hysterectomy?

A hysterectomy removes the uterus, so periods stop regardless of whether ovarian function continues. If the ovaries remain, perimenopause can still occur naturally, but menstrual changes are no longer available as a diagnostic clue.

Assessment may therefore rely more heavily on:

• Age
• Symptoms
• Whether one or both ovaries were removed
• The reason for surgery
• Medication
• Medical history
• Selected blood tests when clinically useful

If both ovaries were removed, surgical menopause usually begins immediately. Symptoms may be more sudden because ovarian hormone production falls abruptly rather than changing gradually.

If the ovaries were retained, a hormone result still provides only a snapshot. Symptoms and clinical history remain important.

Why a normal perimenopause blood test does not invalidate symptoms

People often seek hormone testing because they want objective confirmation that their symptoms have a physical basis.

A normal result can therefore feel dismissive or confusing.

However, a normal reproductive hormone result does not mean:

• The symptoms are imagined
• Perimenopause is impossible
• Treatment cannot be discussed
• No further assessment is needed
• The symptoms are purely psychological

It may simply mean hormone levels were within the laboratory range at the time of testing.

The better question is whether the symptoms, age, cycle history and overall clinical picture are consistent with perimenopause—or whether another condition should be investigated.

Professional interpretation matters because a reference range cannot account for every symptom, medication, cycle stage or individual change. A pharmacist-led results review can help explain what individual markers do and do not show, while identifying findings that may require medical follow-up.

Why an abnormal result may not provide the full answer

An abnormal result can be important, but it should not automatically be treated as a complete diagnosis.

For example:

• A high FSH may support reduced ovarian function, but context and repeat testing may be required
• A low ferritin result may explain some fatigue but not every symptom
• A mildly raised TSH may need repeat or additional thyroid testing
• A low vitamin D result may be relevant without explaining menstrual changes
• A high prolactin result may be temporary or medicine-related
• A raised testosterone result may require further investigation

The practical meaning of a result depends on its severity, related markers, symptoms and whether it persists.

Testing is most useful when there is a clear plan for what happens if the result is normal, borderline or abnormal.

Conditions that can resemble perimenopause

Several medical, psychological and lifestyle-related problems can overlap with perimenopause.

These include:

• Thyroid dysfunction
• Iron-deficiency anaemia
• Pregnancy
• Depression
• Anxiety disorders
• Sleep apnoea
• Medication side effects
• Vitamin B12 deficiency
• Diabetes
• Chronic stress
• Eating disorders or severe dietary restriction
• Hyperprolactinaemia
• Polycystic ovary syndrome
• Premature ovarian insufficiency
• Some autoimmune conditions

This does not mean every person needs an extensive panel of tests. It means symptoms should be considered as a pattern rather than automatically attributed to one cause.

For example, night sweats with unexplained weight loss, fever or persistent swollen glands require a different assessment from longstanding mild hot flushes with increasingly irregular periods.

How to prepare for a useful perimenopause assessment

A well-organised symptom history is often more valuable than a random collection of hormone results.

Before an appointment or test, record:

Your menstrual pattern

Note:

• The first day of each period
• Cycle length
• Missed periods
• Changes in flow
• Bleeding between periods
• Bleeding after sex
• How long bleeding lasts
• Whether clots or flooding occur

Your symptoms

Track symptoms such as:

• Hot flushes
• Night sweats
• Sleep disruption
• Mood changes
• Anxiety
• Problems with concentration
• Headaches
• Joint pain
• Palpitations
• Vaginal dryness
• Pain during sex
• Urinary symptoms
• Changes in sexual desire

A symptom record does not need to be complicated. A short weekly note can show patterns that may be missed when relying on memory.

Medicines and supplements

Include:

• Hormonal contraception
• HRT
• Antidepressants
• Thyroid medication
• Steroids
• Supplements
• Herbal menopause products
• High-dose biotin
• Medicines that may affect bleeding or prolactin

Do not stop prescribed treatment before testing unless you have been advised to do so.

Your wider health history

Mention:

• Pregnancy possibility
• Fertility concerns
• Previous ovarian or uterine surgery
• Family history of early menopause
• Cancer treatment
• Autoimmune conditions
• Thyroid disease
• Blood-clot history
• Migraine
• Unusual or heavy bleeding
• Changes in weight
• Smoking
• Cardiovascular risk factors

This context helps determine whether testing is necessary and which markers are likely to be meaningful.

When perimenopause symptoms need prompt medical assessment

Perimenopause is common, but not every new symptom should automatically be attributed to it.

Seek timely medical advice for:

• Very heavy bleeding
• Bleeding between periods
• Bleeding after sex
• Bleeding after 12 months without a period
• New pelvic pain
• Unexplained weight loss
• Persistent abdominal swelling
• A breast lump or unexplained breast change
• Severe headaches with neurological symptoms
• Fainting, chest pain or marked breathlessness
• New visual disturbance
• Symptoms beginning before the age of 40
• Severe depression, thoughts of self-harm or a mental-health crisis
• Symptoms that are rapidly worsening
• Symptoms that significantly interfere with daily life

Abnormal bleeding often has a benign explanation, but it still deserves appropriate assessment. Blood testing alone may not identify its cause.

Common mistakes when ordering perimenopause blood tests

Expecting one test to prove perimenopause

Perimenopause is not a stable hormonal state. A single result cannot capture changes occurring over months or years.

Treating normal FSH as proof that nothing is happening

FSH may be normal on the day of testing despite genuine symptoms and cycle changes.

Ordering a broad hormone panel without a clinical question

More markers do not necessarily produce a clearer answer. They can produce incidental results that increase uncertainty.

Testing while using hormones without considering their effect

Hormonal contraception and HRT may alter the results and make them difficult to interpret.

Using AMH as a menopause countdown

AMH can contribute to fertility assessment but cannot accurately predict an individual’s final menstrual period.

Chasing an “optimal” hormone level

There is no single ideal oestrogen, progesterone or testosterone result that applies to every person during perimenopause.

Ignoring other causes of symptoms

Fatigue, palpitations, poor sleep, low mood and menstrual changes can have more than one explanation.

Using blood tests instead of investigating abnormal bleeding

A hormone panel cannot replace an appropriate assessment of new, persistent or concerning bleeding.

Frequently asked questions about perimenopause blood tests

Is there one blood test that confirms perimenopause?

No. There is no single blood test that reliably confirms perimenopause in every person. For most people aged 45 and over with typical symptoms, diagnosis is based on symptoms and menstrual changes.

What blood test is used for perimenopause?

FSH is the hormone test most commonly considered, particularly when symptoms begin between 40 and 45 or before the age of 40. Thyroid, iron and other tests may be used to investigate alternative or contributing causes.

Can you be in perimenopause with normal FSH?

Yes. FSH can fluctuate considerably during perimenopause. A normal result does not exclude the transition.

What FSH level means you are in menopause?

There is no single result that should be interpreted without context. Laboratories use different ranges, and the meaning depends on age, symptoms, menstrual history, medicines and whether the result remains elevated.

Can a blood test predict when menopause will happen?

No blood test can accurately predict the exact timing of an individual’s final menstrual period. AMH and FSH may provide limited information about ovarian function, but neither is a reliable personal countdown.

Do you need blood tests before starting HRT?

Not routinely. Most people over 45 with typical symptoms do not need hormone testing before discussing HRT. Other tests may be appropriate when symptoms, medical history or health risks indicate a need.

Do you need regular oestrogen tests while taking HRT?

Routine oestrogen monitoring is not generally required with standard licensed HRT. Treatment is usually reviewed according to symptoms, side effects, bleeding and overall clinical response.

Can perimenopause cause heavy periods?

Yes. Hormonal fluctuations can contribute to heavier, longer or less predictable bleeding. However, new or significant bleeding should not automatically be assumed to be perimenopause without appropriate assessment.

Can perimenopause cause fatigue even when blood tests are normal?

Yes. Sleep disruption, night sweats and hormonal changes may contribute to fatigue even when routine tests are normal. However, thyroid problems, anaemia, medicine effects, sleep disorders and other causes may still need consideration.

Can home menopause tests diagnose perimenopause?

Most home menopause tests measure FSH. Because FSH fluctuates, these tests cannot reliably confirm or rule out perimenopause in an individual. Results should not replace a clinical assessment.

Can I stop contraception after a positive menopause test?

No. A positive FSH or home menopause test does not automatically mean contraception can be stopped. Ovulation can still occur unpredictably, and the appropriate timing depends on age, menstrual history and the contraceptive method being used.

What if all my blood results are normal?

Normal results may make some alternative conditions less likely, but they do not rule out perimenopause. The next step should consider your symptoms, age, menstrual changes, medicines and whether further assessment is needed.

The practical next step

Perimenopause blood tests are most useful when they are used to answer a focused question.

They may help investigate early loss of ovarian function, thyroid disease, anaemia, iron deficiency or another condition that resembles perimenopause. They are far less reliable when used as a universal test intended to prove whether a person is “officially” perimenopausal.

For most otherwise healthy people aged 45 and over, the clearest evidence comes from the combination of age, symptoms and changes in menstrual cycles.

A practical approach is to:

1. Record your symptoms and menstrual changes
2. Consider whether another condition could be contributing
3. Select only the tests that answer a relevant clinical question
4. Interpret the results alongside your history and medication
5. Seek further assessment when symptoms are severe, unusual or begin at a younger age

People who would benefit from a broader review of relevant health markers can explore the Perimenopause MOT. Those who are uncertain which option is appropriate may prefer to book a pharmacist consultation or use the two-minute health quiz before ordering.

The purpose of testing should not be to collect as many hormone values as possible. It should be to understand what the results genuinely add, what they cannot establish and what action—if any—should follow.

This article provides general health information and does not replace an individual assessment, diagnosis or treatment plan.